Archive - March 2018
Japan cuts prices on BMS and Ono’s Opdivo, Merck’s Keytruda: report
Washington insurance commissioner to set protections for short-term plan enrollees
AstraZeneca petitions for longer construction hours at long-delayed HQ
IQVIA Releases Top Medical Group Parent Report
FDA approves 4-week dosing for BMS cancer drug
UnitedHealthcare to pass on drug rebates to some customers
FDA clears DNA test to spot cancer genes, but with warnings
Gilead strikes back at GSK with positive HIV head-to-head trial data for expected blockbuster